Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Piramal Pharma Limited
PPLPHARMAPiramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India. Address: Piramal Ananta, Mumbai, India, 400 070
Analytics
WallStreetin tavoitehinta
–P/E-suhde
704.875Osinkotuotto
0.04 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut PPLPHARMA
Osinkoanalytiikka PPLPHARMA
Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
–Osinkohistoria PPLPHARMA
Osakkeen arvostus PPLPHARMA
Talousasiat PPLPHARMA
Tuloksia | 2019 | Dynamiikka |